Ultrasound-Delivered Hydrogen Reduces Heart Damage in Rats
Acoustic hydrogen delivery to treat PANoptosis induced by myocardial ischemia/reperfusion injury in rats
Research hubs: Cardiovascular System
This research was done in animals. Results in animals often don't carry over to people.
- Evidence type
- Animal study (rat)
- Journal
- Biomaterials Advances
- Year
- 2026
- PMID
- 41671925
- Study Type
- Rat
- Delivery
- Gas (Sustained Release)
- Dose
- intravenous injection of hydrogen-loaded lipid microbubbles followed by ultrasound-targeted microbubble destruction
- H₂ concentration
- (1.14 ± 0.07) × 1010 bubbles/mL
- Outcome
- Positive
- Peer Reviewed
- Yes
- Cited by
- 0 (OpenAlex, as of November 2026)
- Country
- China
TL;DR
Ultrasound-triggered hydrogen microbubbles improved cardiac function and reduced infarct damage after myocardial ischemia/reperfusion by suppressing inflammatory cell death pathways in rats.
Key Finding
Ultrasound-triggered hydrogen-loaded microbubbles significantly improved cardiac function and reduced heart tissue damage in rats with myocardial ischemia/reperfusion injury by suppressing multiple programmed cell death pathways.
Summary
Researchers developed tiny bubbles filled with hydrogen gas that can be injected into the bloodstream and released directly into damaged heart tissue using ultrasound. In rats with heart attack-like injury, this targeted hydrogen delivery improved heart function, reduced the size of damaged areas, and worked by blocking multiple cell death pathways that occur during heart attacks.
Practical Takeaway
This early-stage rat study suggests a novel delivery method for hydrogen gas that could potentially be more effective than drinking hydrogen water, but it is far from human application. The technology requires ultrasound activation and intravenous injection, making it a medical intervention rather than a consumer product. Much more research, including human trials, would be needed before any clinical use.
Abstract (excerpt)
Myocardial ischemia/reperfusion (MIR) injury remains a major clinical challenge with limited therapeutic options. Although molecular hydrogen (H₂) possesses therapeutic potential, its clinical translation is hindered by poor solubility and the lack of targeted delivery and real-time monitoring…